Dear Editor, Non albicans candida has been frequently isolated from clinical samples in our hospital (353 patients) in 2011. Isolation of Candida tropicalis (185 isolates from 114 patients) was only slightly less than Candida albicans (255 isolates from 175 patients). Since early 2011, fi fteen blood cultures from different patients have been reported as positive for pure growth of candida resistant to amphotericin B and fl uconazole. Vitek 2-compact yeast identifi cation card (YST card, Biomeriux France) identifi ed the species as Candida hemulonii. In our case series, fi ve of the patients had sustained candidemia unlike previous reports where candidemia has been reported as a transient phenomenon. [1, 2] In rest of the 10 cases, in view of the clinical features suggestive of systemic infections and the absence of isolation of common bacterial pathogens the likelihood of contamination was ruled out. Our fi rst concern was to determine whether these were hospital acquired infections or not. The time and location of patients at the time of positive blood cultures are indicated in Table 1 . The environmental surveillance culture from the affected intensive care unit (ICU) cubicles and hand swabs from healthcare workers involved in the management of all these patients did not grow any Candida hemulonii. All our patients were adults and there was no evidence of any patient to patient transmission within the hospital.
In two of the cases candidemia had occurred within 48hrs of admission whereas, others were hospitalised for many days before candidemia occurred (mean stay 30 days). In 10 cases there was appearance of candida colonization in urine before candida was isolated from blood. Thirteen cases were on antifungal prophylaxis (mostly fl uconazole) and all had received broad spectrum antibiotics in the past four weeks. Only one person was neutropenic and two cases were on anti-cancer chemotherapy. [3] Sequencing was done on two isolates which identifi ed them as Candida auris. Similar reports of misidentifi cation of Candida auris as C haemulonii by the Vitek 2-compact YST card have been reported from Korea. [4] MIC 50/90 for amphotericin B was 8/16 ug/ml and for fl uconazole was 64/64 ug/ml. Though the exact prevalence of VDE carriage or those causing infections is not yet known, reports of VDE isolated either from stool as gut colonizers as this one or from clinical specimens have been documented. [2] One of the major reasons for these infrequent reports [3] is the requirement of vancomycin enriched medium, which usually is done only as a part of hospital infection control protocol. Even outbreaks due to VDE were identifi ed due to ongoing VRE surveillance programme [4] and clinical isolates mostly following radiometric monitoring of a repeatedly culture negative sample. [3] As proposed, widespread use of third generation cephalosporin along with other broad spectrum antibiotics causes selective pressure to convert the resistant gut Dear Editor, Besides glycopeptide resistance, enterococci show a peculiar phenomenon of glycopeptide dependence. We report the isolation and characterization of vancomycin-dependent Enterococcus faecium (VDE) van A type, from the stool of a patient on intravenous vancomycin therapy.
A 30-year-old female with multiple traumatic injuries was admitted in the intensive care unit (ICU), following explorative laparotomy and prolonged intake of third generation cephalosporin (18 days) and intravenous (iv) vancomycin (5 days). Her blood culture was sterile though her stool sample yielded vancomycin-resistant Enterococcus faecium (VRE) colonies that grew only on media supplemented with vancomycin. The patient fi nally succumbed to her injuries. The isolate's dependence on vancomycin was observed by its sparse growth in vancomycin-free media and dense growth in vancomycin containing media and around vancomycin disc [ Figure 1a ]. The isolate was simultaneously resistant to vancomycin (MIC 256 g/ml, teicoplanin (MIC 32 g/ml), gentamicin (500 g/ml), streptomycin (2000 g/ml), ampicillin (16 g/ml) and ciprofl oxacin (16 g/ml). PCR detected the presence of vanA gene in the isolate [ Figure 1b] . Rate of spontaneous revertants without vancomycin dependence [1] were found in Isolation and characterization of the fi rst vancomycin-dependent Enterococcus from India 
